spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benjamin, L. E.
Right arrow Articles by Keshet, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjamin, L. E.
Right arrow Articles by Keshet, E.
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J. and Keshet, E (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med 1, 1024-1028.[Medline]

Beck, L., Jr. and D'Amore, P. A (1997). Vascular development: cellular and molecular regulation. FASEB 11, 365-373.[Abstract]

Benjamin, L. E. and Keshet, E (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761-8766.[Abstract/Free Full Text]

Brooks, P. C., Clark, R. A. and Cheresh, D. A (1994). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.[Abstract/Free Full Text]

Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.[Medline]

Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, I., Demunck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T. and Collen, D (1996). Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75.[Medline]

Diaz Flores, L., Gutierrez, R., Varela, H., Rancel, N. and Valladares, F (1991). Microvascular pericytes: a review of their morphological and functional characteristics. Histol. Histopathol 6, 269-286.[Medline]

Drake, C. J. and Little, C. D (1995). Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA 92, 7657-7661.[Abstract/Free Full Text]

Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8, 1897-1909.[Abstract/Free Full Text]

Folkman, J. and D'Amore, P. A (1996). Blood vessel formation: what is its molecular basis. Cell 87, 1153-1155.[Medline]

Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A. and Cheresh, D. A (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500-1502.[Abstract/Free Full Text]

Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S. and Cheresh, D. A (1996). Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA 93, 9764-9769.[Abstract/Free Full Text]

Gibson, D. L., Sheps, S. B., Uh, S. H., Schechter, M. T. and McCormick, A. Q (1990). Retinopathy of prematurity-induced blindness: Birth weight-specific survival and the new epidemic. Pediatrics 86, 405-412.[Abstract/Free Full Text]

Leveen, P., Pekny, M., Gebre Medhin, S., Swolin, B., Larsson, E. and Betsholtz, C (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8, 1875-1887.[Abstract/Free Full Text]

Lindahl, P., Johansson, B. R., P., L. and Betsholtz, C (1997). Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice. Science 277, 242-245.[Abstract/Free Full Text]

Mudhar, H.S., Pollock, R.A., Wang, C., Stiles, C.D. and Richardson, W.D (1993). PDGF and its receptors in the developing rodent retina and optic nerve. Development 118, 539-552.[Abstract]

Nehls, V., Denzer, K. and Drenckhahn, D (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270, 469-474.[Medline]

Nicosia, R. F. and Villaschi, S (1995). Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab. Invest 73, 658-666.[Medline]

Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashima, T., Yamashita, J. and Yamamoto, H (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem 270, 28316-28324.[Abstract/Free Full Text]

Orlidge, A. and D'Amore, P. A (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol 105, 1455-1462.[Abstract/Free Full Text]

Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun 181, 902-906.[Medline]

Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A. and Partanen, J (1995). The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14, 5884-5891.[Medline]

Risau, W (1997). Mechanisms of angiogenesis. Nature 386, 631-742.

Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg Buchholz, K., Fujiwara, Y., Gendron Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.[Medline]

Sato, Y. and Rifkin, D. B (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol 109, 309-315.[Abstract/Free Full Text]

Shweiki, D., Itin, A., Soffer, D., Keshet, E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.[Medline]

Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan Ling, T. and Keshet, E (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci 15, 4738-4747.[Abstract]

Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis [see comments]. Cell 87, 1171-1180.[Medline]

Takagi, H., King, G. L. and Aiello, L. P (1996). Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45, 1016-1023.[Abstract]

Vikkula, M., Boon, L. M., Carraway, K. L. r., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., Mulliken, J. B. and Olsen, B. R (1996). Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2 [see comments]. Cell 87, 1181-1190.[Medline]




This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Hilberg, G. J. Roth, M. Krssak, S. Kautschitsch, W. Sommergruber, U. Tontsch-Grunt, P. Garin-Chesa, G. Bader, A. Zoephel, J. Quant, et al.
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Cancer Res., June 15, 2008; 68(12): 4774 - 4782.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. M. Dioum, S. L. Clarke, K. Ding, J. J. Repa, and J. A. Garcia
HIF-2{alpha}-Haploinsufficient Mice Have Blunted Retinal Neovascularization Due to Impaired Expression of a Proangiogenic Gene Battery
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2714 - 2720.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, E. Beaulieu, D. Labbe, V. Bedard, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling
Carcinogenesis, May 1, 2008; 29(5): 1033 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. Tozer, S. Akerman, N. A. Cross, P. R. Barber, M. A. Bjorndahl, O. Greco, S. Harris, S. A. Hill, D. J. Honess, C. R. Ireson, et al.
Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors
Cancer Res., April 1, 2008; 68(7): 2301 - 2311.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. L. McKay, D. J. Gedeon, M. B. Vickerman, A. G. Hylton, D. Ribita, H. H. Olar, P. K. Kaiser, and P. Parsons-Wingerter
Selective Inhibition of Angiogenesis in Small Blood Vessels and Decrease in Vessel Diameter throughout the Vascular Tree by Triamcinolone Acetonide
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1184 - 1190.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. O. Hollinger, C. E. Hart, S. N. Hirsch, S. Lynch, and G. E. Friedlaender
Recombinant Human Platelet-Derived Growth Factor: Biology and Clinical Applications
J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 48 - 54.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle
Early Manifestations of Postnatal Hyperoxia on the Retinal Structure and Function of the Neonatal Rat
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 458 - 466.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Kadenhe-Chiweshe, J. Papa, K. W. McCrudden, J. Frischer, J.-O Bae, J. Huang, J. Fisher, J. H. Lefkowitch, N. Feirt, J. Rudge, et al.
Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
Mol. Cancer Res., January 1, 2008; 6(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Ameri, G. J. Chader, J.-G. Kim, S. R. Sadda, N. A. Rao, and M. S. Humayun
The Effects of Intravitreous Bevacizumab on Retinal Neovascular Membrane and Normal Capillaries in Rabbits
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5708 - 5715.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Van Langendonckt, C. Punyadeera, R. Kamps, G. Dunselman, L. Klein-Hitpass, L.J. Schurgers, J. Squifflet, J. Donnez, and P. Groothuis
Identification of novel antigens in blood vessels in rectovaginal endometriosis
Mol. Hum. Reprod., December 1, 2007; 13(12): 875 - 886.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. M. Fenton and S. F. Paoni
The Addition of AG-013736 to Fractionated Radiation Improves Tumor Response without Functionally Normalizing the Tumor Vasculature
Cancer Res., October 15, 2007; 67(20): 9921 - 9928.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Schmidt, K. Paes, A. De Maziere, T. Smyczek, S. Yang, A. Gray, D. French, I. Kasman, J. Klumperman, D. S. Rice, et al.
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution
Development, August 15, 2007; 134(16): 2913 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. E. Bauman, K. D. Eaton, and R. G. Martins
Antagonism of Platelet-Derived Growth Factor Receptor in Non Small Cell Lung Cancer: Rationale and Investigations
Clin. Cancer Res., August 1, 2007; 13(15): 4632s - 4636s.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. E. Kutcher, A. Y. Kolyada, H. K. Surks, and I. M. Herman
Pericyte Rho GTPase Mediates Both Pericyte Contractile Phenotype and Capillary Endothelial Growth State
Am. J. Pathol., August 1, 2007; 171(2): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. S.N. Shim, I. A.W. Ho, and P. E.H. Wong
Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis
Mol. Cancer Res., July 1, 2007; 5(7): 655 - 665.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. W. Laschke and M. D. Menger
In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis
Hum. Reprod. Update, July 1, 2007; 13(4): 331 - 342.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X. Hao, E. A. Silva, A. Mansson-Broberg, K.-H. Grinnemo, A. J. Siddiqui, G. Dellgren, E. Wardell, L. A. Brodin, D. J. Mooney, and C. Sylven
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction
Cardiovasc Res, July 1, 2007; 75(1): 178 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Ramsauer and P. A. D'Amore
Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization
J. Cell Sci., May 15, 2007; 120(10): 1810 - 1817.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. G. Ball, C. A. Shuttleworth, and C. M. Kielty
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors
J. Cell Biol., May 7, 2007; 177(3): 489 - 500.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. C. Schneider, L. Schilling, H. Schroeck, C. T. Nebe, P. Vajkoczy, and J. Woitzik
Granulocyte-Macrophage Colony-Stimulating Factor-Induced Vessel Growth Restores Cerebral Blood Supply After Bilateral Carotid Artery Occlusion
Stroke, April 1, 2007; 38(4): 1320 - 1328.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Hughes, T. Gardiner, L. Baxter, and T. Chan-Ling
Changes in Pericytes and Smooth Muscle Cells in the Kitten Model of Retinopathy of Prematurity: Implications for Plus Disease
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1368 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. T. Flaherty
Sorafenib in Renal Cell Carcinoma
Clin. Cancer Res., January 15, 2007; 13(2): 747s - 752s.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Zymek, M. Bujak, K. Chatila, A. Cieslak, G. Thakker, M. L. Entman, and N. G. Frangogiannis
The Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2315 - 2323.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. M. Curtis, T. A. Gardiner, and A. W. Stitt
Rod Photoreceptor Loss in Rho-/- Mice Reduces Retinal Hypoxia and Hypoxia-Regulated Gene Expression
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5553 - 5560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Kitadai, T. Sasaki, T. Kuwai, T. Nakamura, C. D. Bucana, and I. J. Fidler
Targeting the Expression of Platelet-Derived Growth Factor Receptor by Reactive Stroma Inhibits Growth and Metastasis of Human Colon Carcinoma
Am. J. Pathol., December 1, 2006; 169(6): 2054 - 2065.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Kociok, S. Radetzky, T. U. Krohne, C. Gavranic, and A. M. Joussen
Pathological but Not Physiological Retinal Neovascularization Is Altered in TNF-Rp55-Receptor-Deficient Mice
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5057 - 5065.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Lederle, H.-J. Stark, M. Skobe, N. E. Fusenig, and M. M. Mueller
Platelet-Derived Growth Factor-BB Controls Epithelial Tumor Phenotype by Differential Growth Factor Regulation in Stromal Cells
Am. J. Pathol., November 1, 2006; 169(5): 1767 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. P. Hall
Review of the Pericyte during Angiogenesis and its Role in Cancer and Diabetic Retinopathy
Toxicol Pathol, October 1, 2006; 34(6): 763 - 775.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ruan, E. Hyjek, P. Kermani, P. J. Christos, A. T. Hooper, M. Coleman, B. Hempstead, J. P. Leonard, A. Chadburn, and S. Rafii
Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non-Hodgkin's Lymphoma.
Clin. Cancer Res., October 1, 2006; 12(19): 5622 - 5631.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Bondjers, L. He, M. Takemoto, J. Norlin, N. Asker, M. Hellstrom, P. Lindahl, and C. Betsholtz
Microarray analysis of blood microvessels from PDGF-B and PDGF-R{beta} mutant mice identifies novel markers for brain pericytes
FASEB J, August 1, 2006; 20(10): 1703 - 1705.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. J. Tomasek, C. J. Haaksma, R. J. Schwartz, D. T. Vuong, S. X. Zhang, J. D. Ash, J.-x. Ma, and M. R. Al-Ubaidi
Deletion of Smooth Muscle {alpha}-Actin Alters Blood-Retina Barrier Permeability and Retinal Function.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2693 - 2700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Jo, C. Mailhos, M. Ju, E. Cheung, J. Bradley, K. Nishijima, G. S. Robinson, A. P. Adamis, and D. T. Shima
Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization
Am. J. Pathol., June 1, 2006; 168(6): 2036 - 2053.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Dell, S. Peters, P. Muther, N. Kociok, and A. M. Joussen
The Role of PDGF Receptor Inhibitors and PI3-Kinase Signaling in the Pathogenesis of Corneal Neovascularization
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1928 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. A. Kunz-Schughart, J. A. Schroeder, M. Wondrak, F. van Rey, K. Lehle, F. Hofstaedter, and D. N. Wheatley
Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro
Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1385 - C1398.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Yamada and N. Takakura
Physiological pathway of differentiation of hematopoietic stem cell population into mural cells
J. Exp. Med., April 17, 2006; 203(4): 1055 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Lee, J. Frischer, A. Serur, J. Huang, J.-O Bae, Z. N. Kornfield, L. Eljuga, C. J. Shawber, N. Feirt, M. Mansukhani, et al.
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
Cancer Res., April 15, 2006; 66(8): 4378 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax
Pericellular Proteases in Angiogenesis and Vasculogenesis
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Morizane, S. Mohri, J. Kosaka, S. Tone, T. Kiyooka, T. Miyasaka, J. Shimizu, Y. Ogasawara, F. Shiraga, Y. Minatogawa, et al.
Iris movement mediates vascular apoptosis during rat pupillary membrane regression
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R819 - R825.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A Martelli, P Berardinelli, V Russo, A Mauro, N Bernabo, L Gioia, M Mattioli, and B Barboni
Spatio-temporal analysis of vascular endothelial growth factor expression and blood vessel remodelling in pig ovarian follicles during the periovulatory period
J. Mol. Endocrinol., February 1, 2006; 36(1): 107 - 119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Roth, M. Piekarek, M. Paulsson, H. Christ, T. Krieg, W. Bloch, J. M. Davidson, and S. A. Eming
Plasmin Modulates Vascular Endothelial Growth Factor-A-Mediated Angiogenesis during Wound Repair
Am. J. Pathol., February 1, 2006; 168(2): 670 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kamba, B. Y. Y. Tam, H. Hashizume, A. Haskell, B. Sennino, M. R. Mancuso, S. M. Norberg, S. M. O'Brien, R. B. Davis, L. C. Gowen, et al.
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H560 - H576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Baffert, T. Le, B. Sennino, G. Thurston, C. J. Kuo, D. Hu-Lowe, and D. M. McDonald
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H547 - H559.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. M. Jubb, H. I. Hurwitz, W. Bai, E. B. Holmgren, P. Tobin, A. S. Guerrero, F. Kabbinavar, S. N. Holden, W. F. Novotny, G. D. Frantz, et al.
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
J. Clin. Oncol., January 10, 2006; 24(2): 217 - 227.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. A. Wiley, B. A. Berkowitz, and J. J. Steinle
Superior Cervical Ganglionectomy Induces Changes in Growth Factor Expression in the Rat Retina
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 439 - 443.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. R. Pradeep, E. S. Sunila, and G. Kuttan
Expression of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptors in Tumor Angiogenesis and Malignancies
Integr Cancer Ther, December 1, 2005; 4(4): 315 - 321.
[Abstract] [PDF]


Home page
Neuro OncolHome page
G. Bergers and S. Song
The role of pericytes in blood-vessel formation and maintenance
Neuro-oncol, October 1, 2005; 7(4): 452 - 464.
[Abstract] [PDF]


Home page
RadiologyHome page
Z. Kan, S. Phongkitkarun, S. Kobayashi, Y. Tang, L. M. Ellis, T. Y. Lee, and C. Charnsangavej
Functional CT for Quantifying Tumor Perfusion in Antiangiogenic Therapy in a Rat Model
Radiology, October 1, 2005; 237(1): 151 - 158.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K. Hamada, T. Sasaki, P. A. Koni, M. Natsui, H. Kishimoto, J. Sasaki, N. Yajima, Y. Horie, G. Hasegawa, M. Naito, et al.
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Genes & Dev., September 1, 2005; 19(17): 2054 - 2065.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Katoh-Fukui, A. Owaki, Y. Toyama, M. Kusaka, Y. Shinohara, M. Maekawa, K. Toshimori, and K.-i. Morohashi
Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression
Blood, September 1, 2005; 106(5): 1612 - 1620.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
G. Thurston, Q. Wang, F. Baffert, J. Rudge, N. Papadopoulos, D. Jean-Guillaume, S. Wiegand, G. D. Yancopoulos, and D. M. McDonald
Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period
Development, July 15, 2005; 132(14): 3317 - 3326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Wedge, J. Kendrew, L. F. Hennequin, P. J. Valentine, S. T. Barry, S. R. Brave, N. R. Smith, N. H. James, M. Dukes, J. O. Curwen, et al.
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Cancer Res., May 15, 2005; 65(10): 4389 - 4400.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. G. Marneros and B. R. Olsen
Physiological role of collagen XVIII and endostatin
FASEB J, May 1, 2005; 19(7): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Dalal, A. M. Berry, C. J. Cullinane, D. C. Mangham, R. Grimer, I. J. Lewis, C. Johnston, V. Laurence, and S. A. Burchill
Vascular Endothelial Growth Factor: A Therapeutic Target for Tumors of the Ewing's Sarcoma Family
Clin. Cancer Res., March 15, 2005; 11(6): 2364 - 2378.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Colnot, L. de la Fuente, S. Huang, D. Hu, C. Lu, B. St-Jacques, and J. A. Helms
Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development
Development, March 1, 2005; 132(5): 1057 - 1067.
[Abstract] [Full Text] [PDF]